Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

NCT00709228 · clinicaltrials.gov ↗

COMPLETED

Status

496

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: PegIntron
DRUG: Rebetol

Sponsor

Merck Sharp & Dohme LLC